Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Repression of androgen receptor transcription through the E2F1/DNMT1 axis.

Valdez CD, Davis JN, Odeh HM, Layfield TL, Cousineau CS, Berton TR, Johnson DG, Wojno KJ, Day ML.

PLoS One. 2011;6(9):e25187. doi: 10.1371/journal.pone.0025187. Epub 2011 Sep 26.

2.

Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.

Altintas DM, Shukla MS, Goutte-Gattat D, Angelov D, Rouault JP, Dimitrov S, Samarut J.

Mol Endocrinol. 2012 Sep;26(9):1531-41. doi: 10.1210/me.2012-1016. Epub 2012 Jul 6.

3.

Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.

Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA, Day ML.

Cancer Res. 2006 Dec 15;66(24):11897-906.

4.

Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.

Li Y, Zhang DY, Ren Q, Ye F, Zhao X, Daniels G, Wu X, Dynlacht B, Lee P.

Mol Cell Biol. 2012 Jul;32(13):2454-66. doi: 10.1128/MCB.06663-11. Epub 2012 Apr 16.

5.

The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer.

Valdez CD, Kunju L, Daignault S, Wojno KJ, Day ML.

Prostate. 2013 Dec;73(16):1776-85. doi: 10.1002/pros.22715. Epub 2013 Sep 4.

7.

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.

Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9.

8.

Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.

Zhou D, Masri S, Ye JJ, Chen S.

Gene. 2005 Nov 21;361:89-100. Epub 2005 Sep 21.

PMID:
16181749
9.

DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.

Milutinovic S, Brown SE, Zhuang Q, Szyf M.

J Biol Chem. 2004 Jul 2;279(27):27915-27. Epub 2004 Apr 15.

10.

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.

Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.

Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.

PMID:
18196538
11.

Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.

Mita P, Savas JN, Djouder N, Yates JR 3rd, Ha S, Ruoff R, Schafler ED, Nwachukwu JC, Tanese N, Cowan NJ, Zavadil J, Garabedian MJ, Logan SK.

Mol Cell Biol. 2011 Sep;31(17):3639-52. doi: 10.1128/MCB.05429-11. Epub 2011 Jul 5.

13.

The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A, Hamburger AW.

Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9890-5. Epub 2005 Jun 30.

14.

The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.

Zhang Y, Akinmade D, Hamburger AW.

Nucleic Acids Res. 2005 Oct 27;33(18):6024-33. Print 2005.

15.

Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.

Estève PO, Chin HG, Pradhan S.

J Biol Chem. 2007 Jan 26;282(4):2615-25. Epub 2006 Nov 22.

16.

Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.

Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL.

Steroids. 1996 Sep;61(9):531-9.

PMID:
8883219
17.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
18.

c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.

Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L.

Oncogene. 2006 Nov 16;25(54):7212-23. Epub 2006 May 29.

PMID:
16732317
19.
20.

Differential requirement of SWI/SNF for androgen receptor activity.

Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE.

J Biol Chem. 2003 Aug 15;278(33):30605-13. Epub 2003 May 29.

Supplemental Content

Support Center